Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.630 | ||
| Révision: | $510.00M | $513.40M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.700 | 0.670 | -0.0300 |
| Révision: | $483.67M | $482.60M | $29.53M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.260 | 1.320 | 0.0600 |
| Révision: | $559.00M | $536.10M | -$8.60M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.080 | 1.260 | 0.1800 |
| Révision: | $531.00M | $502.50M | $46.20M |
